Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study

Aim: To examine the association between the use of incretin-based drugs [glucagon-like peptide-1 receptor agonists (GLP-1RAs), dipeptidyl peptidase-4 inhibitors (DPP-4Is)] and the risk of cholangiocarcinoma (CCA) in the United States. Methods: This large population-based, retrospective cohort study...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Arunkumar Krishnan, Carolin V. Schneider, Hendrik-Tobias Arkenau, Ezequiel Matias Mauro, Alejandro Forner, W. Scott Butsch, Declan Walsh, Saleh A. Alqahtani
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2024-12-01
Cyfres:	Journal of Clinical & Translational Endocrinology
Pynciau:	Incretin Glucagon-like peptide-1 receptor agonists Cholangiocarcinoma Dipeptidyl peptidase 4 inhibitors Type 2 diabetes mellitus
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2214623724000413
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!